Loading...
Myomo, Inc.
MYO•NYSE
Healthcare
Medical - Devices
$2.13
$-0.08(-3.85%)
Myomo, Inc. (MYO) Financial Performance & Statements
Review Myomo, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
69.17%
↑ 69.17%
Operating Income Growth
100.00%
↑ 100.00%
Net Income Growth
100.00%
↑ 100.00%
Operating Cash Flow Growth
46.70%
↑ 46.70%
Operating Margin
-15.11%
↓ 15.11%
Gross Margin
71.18%
↑ 71.18%
Net Profit Margin
-15.05%
↓ 15.05%
ROE
-35.57%
↓ 35.57%
ROIC
-20.00%
↓ 20.00%
Myomo, Inc. (MYO) Financial Statements
Explore quarterly and annual reports for Myomo, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $12.07M | $9.21M | $7.52M | $3.75M |
| Cost of Revenue | $3.45M | $2.26M | $2.20M | $1.46M |
| Gross Profit | $8.62M | $6.95M | $5.33M | $2.30M |
| Gross Profit Ratio | $0.71 | $0.75 | $0.71 | $0.61 |
| R&D Expenses | $1.56M | $1.25M | $1.007M | $956215.00 |
| SG&A Expenses | $7.30M | $6.65M | $5.43M | $5.23M |
| Operating Expenses | $8.86M | $7.90M | $6.44M | $6.19M |
| Total Costs & Expenses | $12.31M | $10.17M | $8.64M | $7.64M |
| Interest Income | $70031.00 | $76020.00 | $107242.00 | $135293.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $466033.00 | $0.00 | $101377.00 | $88343.00 |
| EBITDA | $220719.00 | -$957553.00 | -$1.01M | -$3.80M |
| EBITDA Ratio | $0.02 | -$0.10 | -$0.13 | -$1.01 |
| Operating Income | -$245314.00 | -$957553.00 | -$1.12M | -$3.89M |
| Operating Income Ratio | -$0.02 | -$0.10 | -$0.15 | -$1.04 |
| Other Income/Expenses (Net) | $70031.00 | $76020.00 | $107242.00 | $135293.00 |
| Income Before Tax | -$175283.00 | -$881533.00 | -$1.008M | -$3.75M |
| Income Before Tax Ratio | -$0.01 | -$0.10 | -$0.13 | -$1.00 |
| Income Tax Expense | $84798.00 | $84876.00 | $113785.00 | $82158.00 |
| Net Income | -$260081.00 | -$966409.00 | -$1.12M | -$3.84M |
| Net Income Ratio | -$0.02 | -$0.10 | -$0.15 | -$1.02 |
| EPS | -$0.007 | -$0.03 | -$0.03 | -$0.10 |
| Diluted EPS | -$0.007 | -$0.03 | -$0.03 | -$0.10 |
| Weighted Avg Shares Outstanding | $38.91M | $37.95M | $37.37M | $36.75M |
| Weighted Avg Shares Outstanding (Diluted) | $38.91M | $37.95M | $37.37M | $36.75M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan